Global Pertussis Vaccine Market Analysis and Forecast 2024-2030
Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pertussis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pertussis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Pertussis Vaccine Market by Type
1.2.1 Global Pertussis Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Market by Application
1.3.1 Global Pertussis Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Pertussis Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pertussis Vaccine Revenue by Region
3.2.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pertussis Vaccine Revenue by Region (2019-2024)
3.2.3 Global Pertussis Vaccine Revenue by Region (2025-2030)
3.2.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Pertussis Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Pertussis Vaccine Sales by Region
3.4.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pertussis Vaccine Sales by Region (2019-2024)
3.4.3 Global Pertussis Vaccine Sales by Region (2025-2030)
3.4.4 Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Pertussis Vaccine Revenue by Manufacturers
4.1.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pertussis Vaccine Sales by Manufacturers
4.2.1 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pertussis Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Pertussis Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
4.7 Global Pertussis Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pertussis Vaccine Market CR5 and HHI
4.8.2 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
5 PERTUSSIS VACCINE MARKET BY TYPE
5.1 Global Pertussis Vaccine Revenue by Type
5.1.1 Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pertussis Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Pertussis Vaccine Sales by Type
5.2.1 Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Pertussis Vaccine Price by Type
6 PERTUSSIS VACCINE MARKET BY APPLICATION
6.1 Global Pertussis Vaccine Revenue by Application
6.1.1 Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pertussis Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Pertussis Vaccine Sales by Application
6.2.1 Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Pertussis Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Pertussis Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Comapny Information
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
7.3.5 Mitsubishi Tanabe Pharma Recent Developments
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Comapny Information
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
7.4.5 Wuhan Institute of Biological Products Recent Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Comapny Information
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
7.5.5 Walvax Biotechnology Recent Developments
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Comapny Information
7.6.2 Minhai Biotechnology Business Overview
7.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
7.6.5 Minhai Biotechnology Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Pertussis Vaccine Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 Chengdu Institute of Biological Products
7.8.1 Chengdu Institute of Biological Products Comapny Information
7.8.2 Chengdu Institute of Biological Products Business Overview
7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
7.8.5 Chengdu Institute of Biological Products Recent Developments
8 NORTH AMERICA
8.1 North America Pertussis Vaccine Market Size by Type
8.1.1 North America Pertussis Vaccine Revenue by Type (2019-2030)
8.1.2 North America Pertussis Vaccine Sales by Type (2019-2030)
8.1.3 North America Pertussis Vaccine Price by Type (2019-2030)
8.2 North America Pertussis Vaccine Market Size by Application
8.2.1 North America Pertussis Vaccine Revenue by Application (2019-2030)
8.2.2 North America Pertussis Vaccine Sales by Application (2019-2030)
8.2.3 North America Pertussis Vaccine Price by Application (2019-2030)
8.3 North America Pertussis Vaccine Market Size by Country
8.3.1 North America Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pertussis Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Pertussis Vaccine Market Size by Type
9.1.1 Europe Pertussis Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Pertussis Vaccine Sales by Type (2019-2030)
9.1.3 Europe Pertussis Vaccine Price by Type (2019-2030)
9.2 Europe Pertussis Vaccine Market Size by Application
9.2.1 Europe Pertussis Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Pertussis Vaccine Sales by Application (2019-2030)
9.2.3 Europe Pertussis Vaccine Price by Application (2019-2030)
9.3 Europe Pertussis Vaccine Market Size by Country
9.3.1 Europe Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pertussis Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Pertussis Vaccine Market Size by Type
10.1.1 China Pertussis Vaccine Revenue by Type (2019-2030)
10.1.2 China Pertussis Vaccine Sales by Type (2019-2030)
10.1.3 China Pertussis Vaccine Price by Type (2019-2030)
10.2 China Pertussis Vaccine Market Size by Application
10.2.1 China Pertussis Vaccine Revenue by Application (2019-2030)
10.2.2 China Pertussis Vaccine Sales by Application (2019-2030)
10.2.3 China Pertussis Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pertussis Vaccine Market Size by Type
11.1.1 Asia Pertussis Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Pertussis Vaccine Sales by Type (2019-2030)
11.1.3 Asia Pertussis Vaccine Price by Type (2019-2030)
11.2 Asia Pertussis Vaccine Market Size by Application
11.2.1 Asia Pertussis Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Pertussis Vaccine Sales by Application (2019-2030)
11.2.3 Asia Pertussis Vaccine Price by Application (2019-2030)
11.3 Asia Pertussis Vaccine Market Size by Country
11.3.1 Asia Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pertussis Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Pertussis Vaccine Market Size by Type
12.1.1 MEALA Pertussis Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Pertussis Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Pertussis Vaccine Price by Type (2019-2030)
12.2 MEALA Pertussis Vaccine Market Size by Application
12.2.1 MEALA Pertussis Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Pertussis Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Pertussis Vaccine Price by Application (2019-2030)
12.3 MEALA Pertussis Vaccine Market Size by Country
12.3.1 MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pertussis Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Pertussis Vaccine Value Chain Analysis
13.1.1 Pertussis Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pertussis Vaccine Production Mode & Process
13.2 Pertussis Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pertussis Vaccine Distributors
13.2.3 Pertussis Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Pertussis Vaccine Market by Type
1.2.1 Global Pertussis Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Market by Application
1.3.1 Global Pertussis Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Pertussis Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pertussis Vaccine Revenue by Region
3.2.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pertussis Vaccine Revenue by Region (2019-2024)
3.2.3 Global Pertussis Vaccine Revenue by Region (2025-2030)
3.2.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Pertussis Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Pertussis Vaccine Sales by Region
3.4.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pertussis Vaccine Sales by Region (2019-2024)
3.4.3 Global Pertussis Vaccine Sales by Region (2025-2030)
3.4.4 Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Pertussis Vaccine Revenue by Manufacturers
4.1.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pertussis Vaccine Sales by Manufacturers
4.2.1 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pertussis Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Pertussis Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
4.7 Global Pertussis Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pertussis Vaccine Market CR5 and HHI
4.8.2 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
5 PERTUSSIS VACCINE MARKET BY TYPE
5.1 Global Pertussis Vaccine Revenue by Type
5.1.1 Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pertussis Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Pertussis Vaccine Sales by Type
5.2.1 Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Pertussis Vaccine Price by Type
6 PERTUSSIS VACCINE MARKET BY APPLICATION
6.1 Global Pertussis Vaccine Revenue by Application
6.1.1 Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pertussis Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Pertussis Vaccine Sales by Application
6.2.1 Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Pertussis Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Pertussis Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Comapny Information
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
7.3.5 Mitsubishi Tanabe Pharma Recent Developments
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Comapny Information
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
7.4.5 Wuhan Institute of Biological Products Recent Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Comapny Information
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
7.5.5 Walvax Biotechnology Recent Developments
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Comapny Information
7.6.2 Minhai Biotechnology Business Overview
7.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
7.6.5 Minhai Biotechnology Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Pertussis Vaccine Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 Chengdu Institute of Biological Products
7.8.1 Chengdu Institute of Biological Products Comapny Information
7.8.2 Chengdu Institute of Biological Products Business Overview
7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
7.8.5 Chengdu Institute of Biological Products Recent Developments
8 NORTH AMERICA
8.1 North America Pertussis Vaccine Market Size by Type
8.1.1 North America Pertussis Vaccine Revenue by Type (2019-2030)
8.1.2 North America Pertussis Vaccine Sales by Type (2019-2030)
8.1.3 North America Pertussis Vaccine Price by Type (2019-2030)
8.2 North America Pertussis Vaccine Market Size by Application
8.2.1 North America Pertussis Vaccine Revenue by Application (2019-2030)
8.2.2 North America Pertussis Vaccine Sales by Application (2019-2030)
8.2.3 North America Pertussis Vaccine Price by Application (2019-2030)
8.3 North America Pertussis Vaccine Market Size by Country
8.3.1 North America Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pertussis Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Pertussis Vaccine Market Size by Type
9.1.1 Europe Pertussis Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Pertussis Vaccine Sales by Type (2019-2030)
9.1.3 Europe Pertussis Vaccine Price by Type (2019-2030)
9.2 Europe Pertussis Vaccine Market Size by Application
9.2.1 Europe Pertussis Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Pertussis Vaccine Sales by Application (2019-2030)
9.2.3 Europe Pertussis Vaccine Price by Application (2019-2030)
9.3 Europe Pertussis Vaccine Market Size by Country
9.3.1 Europe Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pertussis Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Pertussis Vaccine Market Size by Type
10.1.1 China Pertussis Vaccine Revenue by Type (2019-2030)
10.1.2 China Pertussis Vaccine Sales by Type (2019-2030)
10.1.3 China Pertussis Vaccine Price by Type (2019-2030)
10.2 China Pertussis Vaccine Market Size by Application
10.2.1 China Pertussis Vaccine Revenue by Application (2019-2030)
10.2.2 China Pertussis Vaccine Sales by Application (2019-2030)
10.2.3 China Pertussis Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pertussis Vaccine Market Size by Type
11.1.1 Asia Pertussis Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Pertussis Vaccine Sales by Type (2019-2030)
11.1.3 Asia Pertussis Vaccine Price by Type (2019-2030)
11.2 Asia Pertussis Vaccine Market Size by Application
11.2.1 Asia Pertussis Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Pertussis Vaccine Sales by Application (2019-2030)
11.2.3 Asia Pertussis Vaccine Price by Application (2019-2030)
11.3 Asia Pertussis Vaccine Market Size by Country
11.3.1 Asia Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pertussis Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Pertussis Vaccine Market Size by Type
12.1.1 MEALA Pertussis Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Pertussis Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Pertussis Vaccine Price by Type (2019-2030)
12.2 MEALA Pertussis Vaccine Market Size by Application
12.2.1 MEALA Pertussis Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Pertussis Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Pertussis Vaccine Price by Application (2019-2030)
12.3 MEALA Pertussis Vaccine Market Size by Country
12.3.1 MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pertussis Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Pertussis Vaccine Value Chain Analysis
13.1.1 Pertussis Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pertussis Vaccine Production Mode & Process
13.2 Pertussis Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pertussis Vaccine Distributors
13.2.3 Pertussis Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Whole-cell Vaccines Major Manufacturers
Table 3. Acellular Vaccines Major Manufacturers
Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. 12 Months Below Major Manufacturers
Table 6. 12 Months Above Major Manufacturers
Table 7. Pertussis Vaccine Industry Trends
Table 8. Pertussis Vaccine Industry Drivers
Table 9. Pertussis Vaccine Industry Opportunities and Challenges
Table 10. Pertussis Vaccine Industry Restraints
Table 11. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
Table 15. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
Table 16. Global Pertussis Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 18. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 19. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 20. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Pertussis Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Pertussis Vaccine Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 26. Global Pertussis Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Pertussis Vaccine Manufacturers, Product Type & Application
Table 29. Global Pertussis Vaccine Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Pertussis Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Pertussis Vaccine Revenue Market Share by Type (2019-2024)
Table 36. Global Pertussis Vaccine Revenue Market Share by Type (2025-2030)
Table 37. Global Pertussis Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 40. Global Pertussis Vaccine Sales Market Share by Type (2019-2024)
Table 41. Global Pertussis Vaccine Sales Market Share by Type (2025-2030)
Table 42. Global Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 43. Global Pertussis Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 44. Global Pertussis Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Pertussis Vaccine Revenue Market Share by Application (2019-2024)
Table 48. Global Pertussis Vaccine Revenue Market Share by Application (2025-2030)
Table 49. Global Pertussis Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 51. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 52. Global Pertussis Vaccine Sales Market Share by Application (2019-2024)
Table 53. Global Pertussis Vaccine Sales Market Share by Application (2025-2030)
Table 54. Global Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 55. Global Pertussis Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 56. Sanofi Pasteur Company Information
Table 57. Sanofi Pasteur Business Overview
Table 58. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 59. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 60. Sanofi Pasteur Recent Development
Table 61. GSK Company Information
Table 62. GSK Business Overview
Table 63. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 64. GSK Pertussis Vaccine Product Portfolio
Table 65. GSK Recent Development
Table 66. Mitsubishi Tanabe Pharma Company Information
Table 67. Mitsubishi Tanabe Pharma Business Overview
Table 68. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 69. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 70. Mitsubishi Tanabe Pharma Recent Development
Table 71. Wuhan Institute of Biological Products Company Information
Table 72. Wuhan Institute of Biological Products Business Overview
Table 73. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 75. Wuhan Institute of Biological Products Recent Development
Table 76. Walvax Biotechnology Company Information
Table 77. Walvax Biotechnology Business Overview
Table 78. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 80. Walvax Biotechnology Recent Development
Table 81. Minhai Biotechnology Company Information
Table 82. Minhai Biotechnology Business Overview
Table 83. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 85. Minhai Biotechnology Recent Development
Table 86. KM Biologics Company Information
Table 87. KM Biologics Business Overview
Table 88. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. KM Biologics Pertussis Vaccine Product Portfolio
Table 90. KM Biologics Recent Development
Table 91. Chengdu Institute of Biological Products Company Information
Table 92. Chengdu Institute of Biological Products Business Overview
Table 93. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 95. Chengdu Institute of Biological Products Recent Development
Table 96. North America Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 97. North America Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 98. North America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 99. North America Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 100. North America Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 101. North America Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 102. North America Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 103. North America Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 104. North America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 105. North America Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 106. North America Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 107. North America Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 108. North America Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 109. North America Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 110. North America Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 111. North America Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 112. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 113. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 114. North America Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 115. North America Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 116. US Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 117. Canada Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 118. Europe Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 119. Europe Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 120. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 121. Europe Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 122. Europe Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 123. Europe Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 124. Europe Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 125. Europe Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 126. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 127. Europe Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 128. Europe Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 129. Europe Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 130. Europe Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. Europe Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 132. Europe Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 133. Europe Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 134. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 135. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 136. Europe Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 137. Europe Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 138. Germany Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 139. France Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 140. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 141. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 142. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 143. China Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 144. China Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 145. China Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 146. China Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 147. China Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 148. China Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 149. China Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 150. China Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 151. China Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 152. China Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 153. China Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 154. China Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 155. Asia Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 156. Asia Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 157. Asia Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 158. Asia Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 159. Asia Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 160. Asia Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 161. Asia Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 162. Asia Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 163. Asia Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 164. Asia Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 165. Asia Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 166. Asia Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 167. Asia Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 168. Asia Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 169. Asia Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 170. Asia Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 171. Asia Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 172. Asia Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 173. Asia Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 174. Asia Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 175. Japan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 176. South Korea Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 177. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 178. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 179. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 180. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 181. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 182. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 183. MEALA Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 184. MEALA Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 185. MEALA Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 186. MEALA Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 187. MEALA Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 188. MEALA Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 189. MEALA Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 190. MEALA Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 191. MEALA Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 192. MEALA Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 193. MEALA Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 194. MEALA Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 195. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 196. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 197. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 198. MEALA Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 199. MEALA Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 200. MEALA Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 201. MEALA Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 202. MEALA Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 203. Mexico Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 204. Brazil Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 205. Israel Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 206. Argentina Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 207. Colombia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 208. Turkey Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 209. Saudi Arabia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 210. UAE Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 211. Key Raw Materials
Table 212. Raw Materials Key Suppliers
Table 213. Pertussis Vaccine Distributors List
Table 214. Pertussis Vaccine Customers List
Table 215. Research Programs/Design for This Report
Table 216. Authors List of This Report
Table 217. Secondary Sources
Table 218. Primary Sources
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Whole-cell Vaccines Major Manufacturers
Table 3. Acellular Vaccines Major Manufacturers
Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. 12 Months Below Major Manufacturers
Table 6. 12 Months Above Major Manufacturers
Table 7. Pertussis Vaccine Industry Trends
Table 8. Pertussis Vaccine Industry Drivers
Table 9. Pertussis Vaccine Industry Opportunities and Challenges
Table 10. Pertussis Vaccine Industry Restraints
Table 11. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
Table 15. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
Table 16. Global Pertussis Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 18. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 19. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 20. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Pertussis Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Pertussis Vaccine Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 26. Global Pertussis Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Pertussis Vaccine Manufacturers, Product Type & Application
Table 29. Global Pertussis Vaccine Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Pertussis Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Pertussis Vaccine Revenue Market Share by Type (2019-2024)
Table 36. Global Pertussis Vaccine Revenue Market Share by Type (2025-2030)
Table 37. Global Pertussis Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 40. Global Pertussis Vaccine Sales Market Share by Type (2019-2024)
Table 41. Global Pertussis Vaccine Sales Market Share by Type (2025-2030)
Table 42. Global Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 43. Global Pertussis Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 44. Global Pertussis Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Pertussis Vaccine Revenue Market Share by Application (2019-2024)
Table 48. Global Pertussis Vaccine Revenue Market Share by Application (2025-2030)
Table 49. Global Pertussis Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 51. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 52. Global Pertussis Vaccine Sales Market Share by Application (2019-2024)
Table 53. Global Pertussis Vaccine Sales Market Share by Application (2025-2030)
Table 54. Global Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 55. Global Pertussis Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 56. Sanofi Pasteur Company Information
Table 57. Sanofi Pasteur Business Overview
Table 58. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 59. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 60. Sanofi Pasteur Recent Development
Table 61. GSK Company Information
Table 62. GSK Business Overview
Table 63. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 64. GSK Pertussis Vaccine Product Portfolio
Table 65. GSK Recent Development
Table 66. Mitsubishi Tanabe Pharma Company Information
Table 67. Mitsubishi Tanabe Pharma Business Overview
Table 68. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 69. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 70. Mitsubishi Tanabe Pharma Recent Development
Table 71. Wuhan Institute of Biological Products Company Information
Table 72. Wuhan Institute of Biological Products Business Overview
Table 73. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 75. Wuhan Institute of Biological Products Recent Development
Table 76. Walvax Biotechnology Company Information
Table 77. Walvax Biotechnology Business Overview
Table 78. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 80. Walvax Biotechnology Recent Development
Table 81. Minhai Biotechnology Company Information
Table 82. Minhai Biotechnology Business Overview
Table 83. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 85. Minhai Biotechnology Recent Development
Table 86. KM Biologics Company Information
Table 87. KM Biologics Business Overview
Table 88. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. KM Biologics Pertussis Vaccine Product Portfolio
Table 90. KM Biologics Recent Development
Table 91. Chengdu Institute of Biological Products Company Information
Table 92. Chengdu Institute of Biological Products Business Overview
Table 93. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 95. Chengdu Institute of Biological Products Recent Development
Table 96. North America Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 97. North America Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 98. North America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 99. North America Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 100. North America Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 101. North America Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 102. North America Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 103. North America Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 104. North America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 105. North America Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 106. North America Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 107. North America Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 108. North America Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 109. North America Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 110. North America Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 111. North America Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 112. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 113. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 114. North America Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 115. North America Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 116. US Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 117. Canada Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 118. Europe Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 119. Europe Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 120. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 121. Europe Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 122. Europe Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 123. Europe Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 124. Europe Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 125. Europe Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 126. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 127. Europe Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 128. Europe Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 129. Europe Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 130. Europe Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. Europe Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 132. Europe Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 133. Europe Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 134. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 135. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 136. Europe Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 137. Europe Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 138. Germany Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 139. France Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 140. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 141. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 142. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 143. China Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 144. China Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 145. China Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 146. China Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 147. China Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 148. China Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 149. China Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 150. China Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 151. China Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 152. China Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 153. China Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 154. China Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 155. Asia Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 156. Asia Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 157. Asia Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 158. Asia Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 159. Asia Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 160. Asia Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 161. Asia Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 162. Asia Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 163. Asia Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 164. Asia Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 165. Asia Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 166. Asia Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 167. Asia Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 168. Asia Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 169. Asia Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 170. Asia Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 171. Asia Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 172. Asia Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 173. Asia Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 174. Asia Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 175. Japan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 176. South Korea Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 177. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 178. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 179. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 180. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 181. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 182. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 183. MEALA Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 184. MEALA Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 185. MEALA Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 186. MEALA Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 187. MEALA Pertussis Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 188. MEALA Pertussis Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 189. MEALA Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 190. MEALA Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 191. MEALA Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 192. MEALA Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 193. MEALA Pertussis Vaccine Sales Price by Application (2019-2024) & (USD/Doses)
Table 194. MEALA Pertussis Vaccine Sales Price by Application (2025-2030) & (USD/Doses)
Table 195. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 196. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 197. MEALA Pertussis Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 198. MEALA Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 199. MEALA Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 200. MEALA Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 201. MEALA Pertussis Vaccine Sales Price by Country (2019-2024) & (USD/Doses)
Table 202. MEALA Pertussis Vaccine Sales Price by Country (2025-2030) & (USD/Doses)
Table 203. Mexico Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 204. Brazil Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 205. Israel Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 206. Argentina Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 207. Colombia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 208. Turkey Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 209. Saudi Arabia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 210. UAE Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Table 211. Key Raw Materials
Table 212. Raw Materials Key Suppliers
Table 213. Pertussis Vaccine Distributors List
Table 214. Pertussis Vaccine Customers List
Table 215. Research Programs/Design for This Report
Table 216. Authors List of This Report
Table 217. Secondary Sources
Table 218. Primary Sources
LIST OF FIGURES
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. Whole-cell Vaccines Picture
Figure 5. Acellular Vaccines Picture
Figure 6. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Pertussis Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 8. 12 Months Below Picture
Figure 9. 12 Months Above Picture
Figure 10. Global Pertussis Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 12. Global Pertussis Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Pertussis Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 16. Global Pertussis Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. China Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 23. Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Pertussis Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Pertussis Vac
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. Whole-cell Vaccines Picture
Figure 5. Acellular Vaccines Picture
Figure 6. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Pertussis Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 8. 12 Months Below Picture
Figure 9. 12 Months Above Picture
Figure 10. Global Pertussis Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 12. Global Pertussis Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Pertussis Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 16. Global Pertussis Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. China Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 23. Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Pertussis Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Pertussis Vac
